SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Rentschler doubles capacity with new single-use bioreactor

By Zachary Brennan+

10-Jun-2014
Last updated on 10-Jun-2014 at 09:55 GMT

German CMO Rentschler Biotechnologie GmbH is adding a 2,000 L single-use bioreactor to its facility in Laupheim, Germany, which it expects to be fully operational by the end of the first quarter of 2015.

The new 2,000 L single-use bioreactor will supplement two existing 1,000 L single-use bioreactors already in operation and will double the company’s total single-use production capacity. The advantages of single-use equipment include a reduction in contamination risks, a faster product turnaround and a shortened setup time that can increase capacity utilization.   

We see an increasing need for production capacity in the mid-scale. The expansion will allow us to match the growing demands of our clients for all clinical phases. The addition of the 2,000 L single-use bioreactor will increase our flexibility to serve the market with either stainless steel or single-use technology as the client requires,” said Frank Ternes, Chief Business Officer at Rentschler. 

Rentschler claims to be one of the first CMOs to establish a fully disposable process concept, with which it now has three years experience. The facility features a flexible space concept comprising four independent, connectable, multi-purpose clean room suites.  

The increase in capacity comes as Rentschler recently won a contract to manufacture a monoclonal antibody candidate for Apeiron Biologics in Austria.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events

 

Access all events listing

Our events, Events from partners...